A recently published clinical study on infusion therapy indicates in-line filters from Pall Corporation (NYSE: PLL) can reduce severe complications and the length of a patient's stay in the pediatric ...
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)-- A recently published clinical study on infusion therapy indicates in-line filters from Pall Corporation (NYSE: PLL) can reduce severe complications and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results